Phosphorylcholine Polymer Regulator for Factor-Deficient APTT Testing

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing blood coagulation tests struggle to accurately detect specimens with coagulation abnormalities such as coagulation factor deficiencies or LA positivity, as they lack sensitivity and specificity in regulating blood coagulation times.

Innovation Solution

A blood coagulation time regulator for specimens deficient in coagulation factors VIII, IX, or XI, utilizing a polymer with 2-methacryloyloxyethyl phosphorylcholine as a constitutional unit, optionally combined with other monomers and additives, to regulate and measure coagulation times in activated partial thromboplastin time (APTT) tests.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If conventional APTT measurement reagents are used, then the test can be performed with standard reagents, but the sensitivity and specificity for detecting coagulation abnormalities (such as FVIII, FIX, or FXI deficiency) are insufficient

Engineering Contradiction:
Improvesensitivity and specificity for detecting coagulation abnormalitiesVSAvoidaccuracy in detecting coagulation factor deficiencies
Core Design Contradiction:
Measurement precisionVSReliability

Solution Approach 1:

The invention changes the chemical composition parameters of the APTT reagent by incorporating a polymer with specific functional groups (carboxyl, hydroxyl, or amino groups) and controlling its molecular weight and concentration. This parameter modification enables the reagent to specifically interact with and detect FVIII, FIX, or FXI deficiency, thereby improving sensitivity and specificity while maintaining reliable measurement accuracy.

Inventive Principle:
Principle #35Parameter changes

2Measurement precision

If the blood coagulation time is not regulated, then the natural coagulation process is preserved, but the ability to precisely detect coagulation abnormalities is compromised

Engineering Contradiction:
Improveprecision in detecting coagulation abnormalitiesVSAvoidcomplexity of coagulation time regulation
Core Design Contradiction:
Measurement precisionVSEase of operation

Solution Approach 1:

The invention introduces a polymer with specific functional groups as an intermediary substance that mediates between the blood specimen and the detection system. This polymer regulates the coagulation time by interacting with coagulation factors, creating a controlled environment that enables precise detection of abnormalities while simplifying the overall measurement process through standardized reagent addition and timing.

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The regulator enables precise detection of coagulation abnormalities by effectively regulating and measuring blood coagulation times, enhancing the sensitivity and accuracy of APTT measurements.

Implementation Method 1

a blood coagulation time regulator for a blood specimen deficient in coagulation factor VIII, IX, or XI in activated partial thromboplastin time (APTT) measurement

Methodology Applied
Scientific EffectCoagulation: Coagulation

Data Source

PatentEP4603840A1Blood coagulation time regulator for blood specimen deficient in coagulation factor viii, ix or xi, and reagent for activated partial thromboplastin time measurement
Publication Date: 2025.08.20 SEKISUI MEDICAL CO LTD
  • EP4603840A1 patent drawing
  • EP4603840A1 patent drawing
  • EP4603840A1 patent drawing

AI summary

A blood coagulation time regulator for a blood specimen deficient in coagulation factor VIII, factor IX, or factor XI in activated partial thromboplastin time measurement includes, as an active ingredient, a polymer having 2-methacryloyloxyethyl phosphorylcholine as a constitutional unit. An activated partial thromboplastin time measurement reagent contains a polymer having 2-methacryloyloxyethyl phosphorylcholine as a constitutional unit and an amino acid.